| |
| |
|
| Insider
Information: |
Mahoney Michael F |
| Relationship: |
Director |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,696,927 |
|
|
Indirect Shares
|
196,852 |
|
|
| Direct
Value |
$127,824,665 |
|
|
|
Indirect Value
|
$14,183,346 |
|
|
| Total
Shares |
1,893,779 |
|
|
| Total
Value |
$142,008,011 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 4.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
Chairman, President & ... |
2024-02-18 |
1,673,878 |
2024-02-18 |
176,245 |
Premium* |
|
|
Baxter International Inc |
BAX |
Director |
2023-05-02 |
9,692 |
2023-05-02 |
20,397 |
Premium* |
|
|
CVS/Caremark Corp |
CVS |
Director |
2024-05-16 |
13,357 |
2024-05-16 |
210 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
190 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2017-01-01 |
4 |
D |
$21.63 |
$1,364,983 |
D/D |
(63,106) |
1,601,858 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2017-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,174 |
1,625,032 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2017-02-22 |
4 |
D |
$25.16 |
$274,345 |
D/D |
(10,904) |
1,614,128 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2017-02-23 |
4 |
D |
$24.48 |
$273,662 |
D/D |
(11,179) |
1,626,707 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2017-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,758 |
1,637,886 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
290,518 |
1,962,961 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2017-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,744 |
2,013,705 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2017-02-28 |
4 |
D |
$24.55 |
$3,941,871 |
D/D |
(160,565) |
1,853,140 |
0 |
- |
|
| BAX |
Baxter International Inc |
Director |
– • – |
2017-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,616 |
5,784 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-01-01 |
4 |
D |
$24.79 |
$1,367,664 |
D/D |
(55,170) |
1,927,216 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
129,246 |
1,982,386 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
237,584 |
2,164,800 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-12 |
4 |
D |
$26.18 |
$2,764,791 |
D/D |
(105,607) |
2,059,193 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,175 |
2,082,368 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-22 |
4 |
D |
$26.48 |
$272,797 |
D/D |
(10,302) |
2,072,066 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-23 |
4 |
D |
$27.20 |
$287,259 |
D/D |
(10,561) |
2,085,263 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,758 |
2,095,824 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,052 |
2,114,315 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-24 |
4 |
D |
$27.20 |
$351,261 |
D/D |
(12,914) |
2,101,401 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
69,074 |
2,170,475 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-28 |
4 |
D |
$27.26 |
$837,018 |
D/D |
(30,705) |
2,139,770 |
0 |
- |
|
| BAX |
Baxter International Inc |
Director |
– • – |
2018-05-08 |
4 |
A |
$69.45 |
$185,015 |
D/D |
2,664 |
2,664 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-09-10 |
4 |
AS |
$35.88 |
$4,186,104 |
D/D |
(116,666) |
2,023,104 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-10-01 |
4 |
AS |
$38.80 |
$4,526,466 |
D/D |
(116,666) |
1,906,438 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-11-01 |
4 |
AS |
$36.35 |
$4,240,739 |
D/D |
(116,666) |
1,789,772 |
0 |
- |
|
190 Records found
|
|
Page 3 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
